This Journal feature begins with a case vignette highlightinga common clinical problem. Evidence supporting various strategiesis then presented, followed by a review of formal guidelines,when they exist. The article ends with the author's clinicalrecommendations.
A healthy 45-year-old man is found on routine screening to havehypertriglyceridemia. He is a nonsmoker, has a reasonable diet,consumes one alcoholic drink per week, and exercises regularly.He takes no medications. His father died at the age of 55 yearsin an automobile accident; his mother is healthy at 67 yearsof age, and he has two healthy older brothers. . . . [Full Text of this Article]
The Clinical Problem
Strategies and Evidence
Evaluation
Management
Lifestyle Modification
Medication
Treatment in Patients with Diabetes
Areas of Uncertainty
Guidelines
Conclusions and Recommendations
Source Information
From the Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, and the Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington, Seattle.
Address reprint requests to Dr. Brunzell at brunzell@u.washington.edu.
Related Letters:
Hypertriglyceridemia
Oh R., Malani A., Ammar H., Mughal S., Brunzell J. D.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:310-311, Jan 17, 2008.
Correspondence
This article has been cited by other articles:
Cefalu, A. B., Noto, D., Arpi, M. L., Yin, F., Spina, R., Hilden, H., Barbagallo, C. M., Carroccio, A., Tarugi, P., Squatrito, S., Vigneri, R., Taskinen, M.-R., Peterfy, M., Averna, M. R.
(2009). Novel LMF1 Nonsense Mutation in a Patient with Severe Hypertriglyceridemia. J. Clin. Endocrinol. Metab.
94: 4584-4590
[Abstract][Full Text]
Perez-Martinez, P., Corella, D., Shen, J., Arnett, D. K, Yiannakouris, N., Tai, E S., Orho-Melander, M., Tucker, K. L, Tsai, M., Straka, R. J, Province, M., Kai, C. S., Perez-Jimenez, F., Lai, C.-Q., Lopez-Miranda, J., Guillen, M., Parnell, L. D, Borecki, I., Kathiresan, S., Ordovas, J. M
(2009). Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am. J. Clin. Nutr.
89: 391-399
[Abstract][Full Text]
Huntington Study Group TREND-HD Investigators,
(2008). Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study. Arch Neurol
65: 1582-1589
[Abstract][Full Text]
Ferns, G, Keti, V, Griffin, B
(2008). Investigation and management of hypertriglyceridaemia. J. Clin. Pathol.
61: 1174-1183
[Abstract][Full Text]
Pullinger, C. R., Aouizerat, B. E., Movsesyan, I., Durlach, V., Sijbrands, E. J., Nakajima, K., Poon, A., Dallinga-Thie, G. M., Hattori, H., Green, L. L., Kwok, P.-Y., Havel, R. J., Frost, P. H., Malloy, M. J., Kane, J. P.
(2008). An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J. Lipid Res.
49: 1846-1854
[Abstract][Full Text]
Despres, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodes-Cabau, J., Bertrand, O. F., Poirier, P.
(2008). Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk. Arterioscler. Thromb. Vasc. Bio.
28: 1039-1049
[Abstract][Full Text]
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., Witztum, J. L.
(2008). Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol
51: 1512-1524
[Full Text]
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., Witztum, J. L.
(2008). Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care
31: 811-822
[Full Text]
Oh, R., Malani, A., Ammar, H., Mughal, S., Brunzell, J. D.
(2008). Hypertriglyceridemia.. NEJM
358: 310-310
[Full Text]
Previous
